Pierce: Im Out of Empathy. Im Out of Pity. Im Out of

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
192
Quote:
Pierce: Im Out of Empathy. Im Out of Pity. Im Out of Patience.


...Any report about Roy Moore that doesn’t specifically refer to him as a right-wing extremist is not worth your time. No more “firebrand.” No more impotent yap about his “controversial views.” Roy Moore is an extremist or the word no longer has meaning.

If, as appears likely, he gets elected to the Senate from Alabama, then a majority of Alabama voters are extremists, too. If he gets elected, then the Republican Party ever more should be referred to as an extremist party. That, of course, is if we’re being honest about what’s really going on in this country in 2017.

And, no, when it comes to the people who voted for Moore, I don’t have to “respect their beliefs.” I don’t have to “understand where they’re coming from.” I don’t have to “see it from their side.” These people are preparing to make a lawless theocratic lunatic one of 100 United States Senators, and that means these people are about to inflict him and his medievalism on me, too.

If you think that Roy Moore belongs in the Senate, then you are a half-bright goober whose understanding of American government and basic civics probably stops at the left side of your AM radio dial.

You have no concept of the national interest and very little concept of your own, unless, as I suspect, you’ve made your own fears, and hating people and hawking loogies in all directions, the sum total of your involvement in self-government.

You are killing democracy and you don’t know it or care. If you had any real Christian charity in your hearts, you’d keep Roy Moore in the locked ward of your local politics and not loose him on a nation that deserves so much better than him....

The Senate’s tax plan emerged full-grown from the forehead of Mania on Tuesday. As is customary for some documents, it is vague in almost all its major details. But we do know that it eliminates the estate tax entirely—a plutocratic goodie that probably caused a postmortem emission from the grave of John D. Rockefeller that looked like the gusher from his first oil well—and it gives to the middle class with one hand while taking it away from the other, thereby robbing Peter to bribe Paul.

Ultimately, the estimates are that it will cost the federal treasury $1.5 trillion over the next decade, and the people pushing it decline to say how they’re going to make that cut pay for itself, proving that the Republicans at least continue to adhere to the first half of the blog’s First Law of Economics, to wit: Fck The Deficit. The only details that are clear about the plan are the ones that benefit the country’s real owners.

What I do know is that the people who elected Roy Moore elected him to join the Senate majority that will pass this thing, if and when it ever comes to a vote. Then, come some April morn, they will be stunned to discover that they can’t deduct what they pay in state taxes anymore, and that their charitable contributions don’t count any more either. How could ol’ Judge Roy let this happen?


Because he’s a lawless theocratic lunatic, that’s how. Because you voted for him specifically because he was a lawless theocratic lunatic. It was the basis of his campaign, no matter how many times Steve Bannon tells you you’re part of a bold populist crusade.

He very likely doesn’t know enough about tax policy to throw to the cat, so he’ll go along on that as long as they let him make his floor speeches about how Cecile Richards is an imp from hell. (Condom: The Devil’s Party Hat.) And you’ll cheer him so loudly that you won’t even notice that your pocket’s being picked again by someone with a solid-gold Rolex on his wrist.

I’m out of empathy for this stuff. I’m out of pity. I’m out of patience. And, not for nothing, but Moore’s opponent is a guy named Douglas Jones. In 2001, Jones convicted two men for the bombing of the 16th Street Baptist Church in Birmingham in 1963, one of the iconic white supremacist terrorist acts of that period.

One of those bastards already died in prison and the other keeps getting denied parole. If you’d rather be represented in the Senate by a lawless theocratic lunatic, rather than a guy that finally got justice for four murdered little girls, well, you deserve anything that goddamn happens to you.

http://www.esquire.com/news-politics/politics...roy-moore/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 233

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 351

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 115

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 116

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading